US FDA to hold off action on weight-loss drug copies pending court ruling

 The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of Novo Nordisk's (NOVOb.CO) , opens new tab weight-loss drug Wegovy until a federal court delivers its ruling in a lawsuit against the agency.

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-hold-off-action-weight-loss-drug-copies-pending-court-ruling-2025-03-10/